Contact
Please use this form to send email to PR contact of this press release:
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
TO:
Please use this form to send email to PR contact of this press release:
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
TO: